Cardiac efficiency is improved after ischemia by altering both the source and fate of protons

Circulation Research

Volumn 79, Issue 5, 1996, Pages 940-948

  Liu, Bin ^a   Clanachan, Alexander S ^a   Schulz, Richard ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

fatty acid oxidation; glucose oxidation; glycolysis; lactate oxidation; Na+ H+ exchanger; reperfusion

Indexed keywords

PROTON PUMP;

ANIMAL EXPERIMENT; ARTICLE; FATTY ACID OXIDATION; GLUCOSE OXIDATION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART WORK; MALE; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RAT;

EID: 0029998606     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.5.940     Document Type: Article

References (43)

1. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol. 1974;36:413-459.
2. Dennis SC, Gevers W, Opie LH. Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol. 1991;23: 1077-1086.
3. 2+ exchange. Circ Res. 1989;65:1045-1056.
4. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation. 1989;80:1049-1062.
5. 2+ overload in isolated perfused rabbit heart. Circulation. 1994; 89:2787-2798.
6. 2+ homeostasis in hearts reperfused after prolonged episodes of ischemia. Ann N Y Acad Sci. 1994;723:38-50.
7. + exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res. 1993;27:915-924.
8. + exchange and its inhibition in cardiac ischemia and reperfusion. Basic Res Cardiol. 1993;88:443-455.
9. 2+ overload in reperfused ischemic myocardium. Annu Rev Physiol. 1990;52:543-559.
10. Murphy E, Perlman M, London RE, Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res. 1991; 68:1250-1258.
11. Lopaschuk GD, Wambolt RB, Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther. 1993;264:135-144.
12. 2 during reperfusion of ischemic hearts. Am J Physiol. 1996;270:H72-H80.
13. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta. 1994;1213:263-276.
14. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res. 1988;62:535-542.
15. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res. 1990;66:546-553.
16. Lerch R, Tamm C, Papageorgiou I, Benzi RH. Myocardial fatty acid oxidation during ischemia and reperfusion. Mol Cell Biochem. 1992; 116:103-109.
17. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. J Biol Chem. 1992;267:3825-3831.
18. Randle PJ. Fuel selection in animals. Biochem Soc Trans. 1986;14: 799-806.
19. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem. 1991;266:8162-8170.
20. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol. 1994;267: H742-H750.
21. Opie LH. Myocardial ischemia-metabolic pathways and implications of increased glycolysis. Cardiovasc Drugs Ther. 1990;4(suppl): 777-790.
22. Hochachka PW, Mommsen TP. Protons and anerobiosis. Science. 1983;219:1391-1397.
23. + exchange system. Circ Res. 1994;74:794-805.
24. Stacpoole PW, The pharmacology of dichloroacetate. Metabolism. 1989;38:1124-1144.
25. McVeigh JJ, Lopaschuk GD. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol. 1990;259:H1079-H1085.
26. Finegan BA, Clanachan AS, Coulson CS, Lopaschuk GD. Adenosine modification of energy substrate use in isolated hearts perfused with fatty acids. Am J Physiol. 1992;262:H150I-H1507.
27. Liedtke AJ, Renstrom B, Nellis SH, Hall JL, Stanley WC. Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis. J Am Coll Cardiol. 1995;26:815-825.
28. Benzi RH, Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Circ Res. 1992; 71:567-576.
29. Racey-Burns LA, Burns AH, Summer WR, Shepherd RE. The effect of dichloroacetate on the isolated no flow arrested rat heart. Life Sci. 1989;44:2015-2023.
30. Wahr JA, Childs KF, Boiling SF. Dichloroacetate enhances myocardial functional and metabolic recovery following global ischemia. J Cardiothorac Vasc Anesth. 1994;8:192-197.
31. Lewandowski ED, White LT. Pyruvate dehydrogenase influences postischemic heart function. Circulation. 1995;91:2071-2079.
32. Patel MS, Roche TE. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J. 1990;4:3224-3233.
33. Broderick TL, Quinney HA, Barker CC, Lopaschuk GD. Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation. 1993;87:972-981.
34. Schonekess BO, Allard MF, Lopaschuk GD. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res. 1995;77:726-734.
35. McCormack JG, Barr RL, Wolff AA, Lopaschuk GD. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation. 1996;93:135-142.
36. Lopaschuk GD, Wall SR, Olley PM, Davies NJ. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ Res. 1988;63:1036-1043.
37. Bunger R, Mallet RT, Hartman DA. Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart: near-complete prevention of reperfusion contractile failure. Eur J Biochem. 1989;180:221-233.
38. Davies NJ, McVeigh JJ, Lopaschuk GD. Effects of TA-3090, a new calcium channel blocker, on myocardial substrate utilization in ischemic and nonischemic isolated working fatty acid-perfused rat hearts. Circ Res. 1991;68:807-817.
39. Fabiato A, Fabiato F. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscle. J Physiol (Land). 1978;276:233-255.
40. Finegan BA, Lopaschuk GD, Coulson SC, Clanachan AS. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation. 1993;87:900-908.
41. Meng H, Pierce GN. Protective effects of 5-(N,N-dimethyl)-amiloride on ischemia-reperfusion injury in hearts. Am J Physiol. 1990;258:H1615-1619.
42. Meng H, Maddaford TG, Pierce GN. Effect of amiloride and selected analogues on postischemic recovery of cardiac contractile function. Am J Physiol. 1993;264:H1831-H1835.
43. Kleyman TR, Cragoe EJ Jr. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol. 1988;105:1-21.